Bliss GVS Pharma Limited (BLISSGVS.NS) NSE

169.46

+2.59(+1.55%)

Updated at December 05 12:49PM

Currency In INR

Valuation

Market Cap12.65B
Enterprise Value13.29B
P/E Ratio16.15
PEG Ratio6.06
Price/Sales Ratio2.06
Price/Book Ratio1.56
Enterprise/Revenue1.89
Enterprise/EBITDA7.87

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.13
Operating Margin0.11

Management Effectiveness

Return On Assets0.08
Return On Equity0.1

Income Statement

Revenue8.1B
Revenue/Share81.45
Gross Profit3.96B
EBITDA1.27B
Net Income842.99M
Diluted EPS7.95

Balance Sheet

Total Cash2.01B
Total Cash/Share18.99
Total Debt524.91M
Total Debt/Equity0.05
Current Ratio4.46
Book Value Per Share110.6

Price History

52-Week Change4.15
52-Week High190.97
52-Week Low108.12
Moving Average 50 Days155.6
Moving Average 200 Days144.37

Statistics

Average Volume1.2M
Shares Outstanding105.72M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.5
Trailing Annual Dividend Yield0.3
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A